Key facts
- This page summarizes James F. Young's Form 4 filing for NOVAVAX INC (NVAX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jan 2025, 16:44.
James F. Young - 24 Dec 2024 Form 4 Insider Report for NOVAVAX INC (NVAX)
- Reporting relationship
- Director
- Issuer ticker
- NVAX
- Reported as of
- 24 Dec 2024
- Net transaction value
- -$82,208
- SEC form
- 4
- Accepted by SEC
- 02 Jan 2025, 16:44:15 UTC
- Prior SEC filing
- 25 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/Mark J. Casey, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
James F. Young filed Form 4 for NOVAVAX INC (NVAX) on 02 Jan 2025.
Change
- Previous filing in this sequence was filed on 25 Jun 2024.
- Current net transaction value: -$82,208.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NVAX
transaction
Common Stock
Sale
- Transaction value
- $39,008
- Shares
- -4,600
- Change %
- -7.4%
- Price
- $8.48
- Shares after
- 57,160
- Date
- 24 Dec 2024
- Ownership
- Direct
NVAX
transaction
Common Stock
Sale
- Transaction value
- $43,200
- Shares
- -5,400
- Change %
- -9.4%
- Price
- $8.00
- Shares after
- 51,760
- Date
- 31 Dec 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.